UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 31, 2014
Accession Number:
0001144204-14-015392
Submission Type:
POS AM
CIK:
0001541157
Company Name:
Celsus Therapeutics Plc.
File Number:
333-185247